Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Marsoni

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2019
Plasma HER2 (<i>ERBB2</i>) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal CancerGiulia Siravegna, Andrea Sartore-Bianchi, Rebecca J Nagy, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2009
Clinical pharmacokinetics of the new oral camptothecin gimatecan: the inter-patient variability is related to alpha1-acid glycoprotein plasma levelsRoberta Frapolli, Massimo Zucchetti, Cristiana Sessa, et al.
Cancers|March 10, 2022
Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective StudyAlessio Amatu, Gianluca Mauri, Federica Tosi, et al.
EMBO Reports|August 5, 2020
Amyloid aggregates accumulate in melanoma metastasis modulating YAP activityVittoria Matafora, Francesco Farris, Umberto Restuccia, et al.
ESMO Open|December 18, 2018
Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysisMarina Chiara Garassino, Tomoya Kawaguchi, Vanesa Gregorc, et al.
Journal of the National Cancer Institute|May 20, 2004
Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinomaRoberto Labianca, Roldano Fossati, Alberto Zaniboni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 17, 2013
A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancerFilippo de Marinis, Akin Atmaca, Marcello Tiseo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes failsCristiana Sessa, Filippo De Braud, Antonella Perotti, et al.
European Radiology Experimental|November 10, 2020
Impact of inter-reader contouring variability on textural radiomics of colorectal liver metastasesFrancesco Rizzetto, Francesca Calderoni, Cristina De Mattia, et al.
Journal of the National Cancer Institute|May 21, 2011
DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapyFrank A Sinicrope, Nathan R Foster, Stephen N Thibodeau, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2019
Plasma HER2 (<i>ERBB2</i>) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal CancerGiulia Siravegna, Andrea Sartore-Bianchi, Rebecca J Nagy, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2009
Clinical pharmacokinetics of the new oral camptothecin gimatecan: the inter-patient variability is related to alpha1-acid glycoprotein plasma levelsRoberta Frapolli, Massimo Zucchetti, Cristiana Sessa, et al.
Cancers|March 10, 2022
Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective StudyAlessio Amatu, Gianluca Mauri, Federica Tosi, et al.
EMBO Reports|August 5, 2020
Amyloid aggregates accumulate in melanoma metastasis modulating YAP activityVittoria Matafora, Francesco Farris, Umberto Restuccia, et al.
ESMO Open|December 18, 2018
Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysisMarina Chiara Garassino, Tomoya Kawaguchi, Vanesa Gregorc, et al.
Journal of the National Cancer Institute|May 20, 2004
Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinomaRoberto Labianca, Roldano Fossati, Alberto Zaniboni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 17, 2013
A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancerFilippo de Marinis, Akin Atmaca, Marcello Tiseo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes failsCristiana Sessa, Filippo De Braud, Antonella Perotti, et al.
European Radiology Experimental|November 10, 2020
Impact of inter-reader contouring variability on textural radiomics of colorectal liver metastasesFrancesco Rizzetto, Francesca Calderoni, Cristina De Mattia, et al.
Journal of the National Cancer Institute|May 21, 2011
DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapyFrank A Sinicrope, Nathan R Foster, Stephen N Thibodeau, et al.
Pageof 9